Member Record


Membership Category
Professional Publisher (Small)
ecancer Global Foundation (Charity Number 1176307)
Main Address
ecancer Global Foundation
13 King Square Avenue
Bristol BS2 8HU
Other Office Locations
Copyright and Licensing Link
Copyright and Licensing Policy
Authors will be asked to agree to an exclusive license agreement which states that anyone is free:
  • to copy, distribute, and display the work;
  • to make derivative works;
  • to make commercial use of the work.
Under the following conditions:Attribution
  • the original author must be given credit (but not in any way that suggests that they endorse you or your use of the work);
  • for any re-use or distribution, it must be made clear to others what the license terms of this work are;
  • any of these conditions can be waived if the authors give permission.
Statutory fair use and other rights are in no way affected by the above.
Complaint Contact Link
Complaint Policy
If an author believes that an editor has made an error in declining a paper, we welcome an appeal. In your appeal letter to the editor, please state why you think the decision is mistaken. At least two editors decide whether to invite a revised manuscript and whether re-review, or otherwise, is warranted. Authors who have appealed against a rejection but remain concerned about the editorial process can refer their case to COPE. ecancermedicalscience endorses the World Association of Medical Editors (WAME) Policy Statement on Geopolitical Intrusion on Editorial Decisions.
Publication Charge Link
Publication Charge Policy
We charge authors that have received funding specifically allocated to publication of their articles in an open access journal.
OASPA Compliant OA Journals
OA Articles (approx. number in 12 months)
814 articles to date
OASPA Compliant OA Books
Peer Review Process Link
Peer Review Policy will be reviewed by one editor and subsequently by one or more experts, with the aim of reaching a first decision as soon as possible, ideally within a month. Statistical reviewers from the European Institute of Oncology and elsewhere may also be used where required.Reviewers are asked whether the manuscript is scientifically sound and how interesting and innovative it is. The ultimate responsibility for any decision lies with the Editor.Reviewers are also asked to indicate which articles they consider to be especially significant for clinical application or public health. These articles may be given greater prominence and included in an editorial and/or ecancermedicalscience press release.

Once an article is accepted, html and pdf versions are published within two weeks on Authors will be able to check the progress of their paper through the submission system at any time by logging in.

The journal includes a large collection of video interviews with cancer experts at conferences, free accredited education modules for CME and includes Spanish translations for some articles.

View Our Member Directory

View our directory of current OASPA members.